<- Go Home

LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Market Cap

$68.1M

Volume

91.4K

Cash and Equivalents

$12.5M

EBITDA

-$11.8M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$26.4M

Profit Margin

45.71%

52 Week High

$14.20

52 Week Low

$5.06

Dividend

N/A

Price / Book Value

6.31

Price / Earnings

2.47

Price / Tangible Book Value

11.69

Enterprise Value

$71.0M

Enterprise Value / EBITDA

-6.39

Operating Income

-$16.4M

Return on Equity

362.55%

Return on Assets

-14.73

Cash and Short Term Investments

$13.5M

Debt

$2.6M

Equity

$24.6M

Revenue

$57.7M

Unlevered FCF

-$17.2M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches